Chita-gun, Japan

Yoriko Ohashi


Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • Aichi-ken, JP (2002)
  • Chita-gun, JP (2002 - 2005)

Company Filing History:


Years Active: 2002-2005

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yoriko Ohashi: Innovator in Pharmaceutical Chemistry

Introduction

Yoriko Ohashi is a prominent inventor based in Chita-gun, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. With a total of 3 patents, her work has garnered attention in the scientific community.

Latest Patents

Ohashi's latest patents include innovative compounds such as benzimidazole compounds that act as ORL1-receptor agonists. These compounds are characterized by a specific formula that includes various substituents, making them useful as analgesics in mammalian subjects. Another notable patent is for 1,3,8-triuazaspiro(4,5)decanone compounds, which also serve as ORL1-receptor agonists. These advancements highlight her commitment to developing effective pharmaceutical solutions.

Career Highlights

Throughout her career, Ohashi has been associated with Pfizer Corporation, a leading global pharmaceutical company. Her work at Pfizer has allowed her to focus on innovative research and development in the field of drug discovery. Her contributions have not only advanced scientific knowledge but also have the potential to improve patient care.

Collaborations

Ohashi has collaborated with esteemed colleagues such as Fumitaka Ito and Hirohide Noguchi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of her research.

Conclusion

Yoriko Ohashi's contributions to pharmaceutical chemistry exemplify her dedication to innovation and research. Her patents reflect her expertise and commitment to developing new therapeutic options. As she continues her work, her impact on the field is likely to grow, benefiting both the scientific community and patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…